Surgepays Stock Filter Stocks by Fundamentals
SURG Stock | USD 1.84 0.02 1.08% |
Surgepays fundamentals help investors to digest information that contributes to Surgepays' financial success or failures. It also enables traders to predict the movement of Surgepays Stock. The fundamental analysis module provides a way to measure Surgepays' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Surgepays stock.
Surgepays | Cash and Equivalents |
Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
All Next | Launch Module |
Surgepays Fundamentals
Return On Equity | -0.0519 | ||||
Return On Asset | -0.0151 | ||||
Profit Margin | (0.01) % | ||||
Operating Margin | (0.72) % | ||||
Current Valuation | 18.27 M | ||||
Shares Outstanding | 20.16 M | ||||
Shares Owned By Insiders | 31.90 % | ||||
Shares Owned By Institutions | 8.72 % | ||||
Number Of Shares Shorted | 361.27 K | ||||
Price To Earning | 11.14 X | ||||
Price To Book | 1.12 X | ||||
Price To Sales | 0.33 X | ||||
Revenue | 137.14 M | ||||
Gross Profit | 13.47 M | ||||
EBITDA | 20.08 M | ||||
Net Income | 20.62 M | ||||
Cash And Equivalents | 8.7 M | ||||
Cash Per Share | 0.70 X | ||||
Total Debt | 5.44 M | ||||
Debt To Equity | 6.32 % | ||||
Current Ratio | 1.07 X | ||||
Book Value Per Share | 1.96 X | ||||
Cash Flow From Operations | 10.29 M | ||||
Short Ratio | 3.13 X | ||||
Earnings Per Share | (1.18) X | ||||
Price To Earnings To Growth | 0.53 X | ||||
Target Price | 6.0 | ||||
Number Of Employees | 22 | ||||
Beta | 1.39 | ||||
Market Capitalization | 37.5 M | ||||
Total Asset | 41.93 M | ||||
Retained Earnings | (15.19 M) | ||||
Working Capital | 20.66 M | ||||
Current Asset | 46.28 M | ||||
Current Liabilities | 9.69 M | ||||
Net Asset | 41.93 M |
About Surgepays Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Surgepays's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surgepays using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surgepays based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Surgepays is a strong investment it is important to analyze Surgepays' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Surgepays' future performance. For an informed investment choice regarding Surgepays Stock, refer to the following important reports:Check out Surgepays Piotroski F Score and Surgepays Altman Z Score analysis. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Wireless Telecommunication Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgepays. If investors know Surgepays will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgepays listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.78) | Earnings Share (1.18) | Revenue Per Share 6.864 | Quarterly Revenue Growth (0.58) | Return On Assets (0.02) |
The market value of Surgepays is measured differently than its book value, which is the value of Surgepays that is recorded on the company's balance sheet. Investors also form their own opinion of Surgepays' value that differs from its market value or its book value, called intrinsic value, which is Surgepays' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgepays' market value can be influenced by many factors that don't directly affect Surgepays' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgepays' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgepays is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgepays' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.